How do you diagnose peritonitis in a Peritoneal Dialysis (PD) patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Peritonitis in Peritoneal Dialysis Patients

The diagnosis of peritonitis in peritoneal dialysis (PD) patients requires a peritoneal fluid white blood cell (WBC) count ≥230/μL with >50% neutrophils, along with clinical symptoms such as abdominal pain, cloudy dialysate, and fever. 1

Diagnostic Criteria

Laboratory Testing

  • Peritoneal fluid analysis:
    • Collect effluent dialysate using the "aliquot method":
      • Shake each bag of effluent vigorously
      • Empty into a measuring container
      • Record the volume
      • Take appropriate sample for laboratory testing 2
    • WBC count ≥230/μL provides optimal sensitivity (98%) and specificity (89%) 1
    • Neutrophil predominance (>50% of WBCs) 1
    • Culture of dialysate effluent (positive in approximately 80% of cases) 3

Clinical Presentation

  • Cloudy dialysate - the most consistent sign
  • Abdominal pain - may vary from mild to severe
  • Fever - not always present but increases diagnostic certainty
  • Nausea/vomiting - common accompanying symptoms
  • Elevated C-reactive protein - supports diagnosis when present 1

Diagnostic Algorithm

  1. Assess for cloudy dialysate and abdominal symptoms
  2. Collect peritoneal fluid sample using aliquot method
  3. Perform cell count and differential:
    • If WBC ≥230/μL with >50% neutrophils → Diagnose peritonitis
    • If WBC <230/μL without fever or elevated CRP → Peritonitis unlikely (99.8% sensitivity for exclusion) 1
  4. Send for culture and sensitivity (aerobic, anaerobic, and fungal)
  5. Initiate empiric antibiotics while awaiting culture results

Special Considerations

Culture-Negative Peritonitis

  • Occurs in up to 20% of cases 3
  • Consider:
    • Prior antibiotic exposure
    • Improper culture technique
    • Unusual organisms requiring special media
    • Non-infectious causes (chemical, eosinophilic)
    • Possible enteric source if symptoms persist despite antibiotics 4

Fungal Peritonitis

  • Accounts for 3-6% of peritonitis episodes
  • Risk factors:
    • Prior bacterial peritonitis (87.5% of cases)
    • Recent broad-spectrum antibiotic use 5
  • Requires immediate catheter removal and antifungal therapy 2

Timing Considerations

  • Do not perform peritoneal membrane function testing during or within 1 month after peritonitis, as results will be inaccurate due to temporary changes in transport characteristics 2
  • Peritoneal transport increases during peritonitis and usually recovers within 1 month after resolution 6

Pitfalls to Avoid

  1. Using outdated diagnostic thresholds - The traditional cutoff of 100/μL WBC has only 35% specificity; using 230/μL improves specificity to 89% without compromising sensitivity 1

  2. Delaying diagnosis of enteric peritonitis - Persistent symptoms despite appropriate antibiotics should prompt investigation for intestinal sources (e.g., mesenteric ischemia, diverticulitis) 4

  3. Missing fungal peritonitis - Consider fungal etiology in patients with recent antibiotic exposure and non-resolving or recurrent peritonitis 5

  4. Performing membrane transport testing too soon - Wait at least 1 month after peritonitis resolution before assessing peritoneal membrane function 2

References

Guideline

Peritoneal Dialysis-Associated Peritonitis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sterile peritonitis in the peritoneal dialysis patient.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2005

Research

Fungal peritonitis in peritoneal dialysis: a 10 year retrospective analysis in a single center.

European review for medical and pharmacological sciences, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.